✉news HealthMedicine first seen 5 h ago, last 7 min ago, peak #5
Phase 1 trial tests Werner helicase inhibitor in MSI tumors
Original: Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial
A phase 1 clinical trial is testing a Werner helicase inhibitor in patients with advanced microsatellite instability-high solid tumors, according to a report published in Nature. The approach targets a DNA repair vulnerability in these cancers, which often resist standard therapies. Early-stage results will determine safety, dosing and whether the drug warrants further development.
Why now: Interest in a novel targeted therapy for hard-to-treat MSI-high cancers reported in Nature.
Werner helicase inhibitorNaturemicrosatellite instability-high solid tumors
Rank over time, top of the chart is #1. 5 snapshots from 5 h ago to 7 min ago.
Evidence
- Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial · Nature
API: https://socialmediatrends-api.osmike.com/v1/trends/379668